NCT03583905

Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet

A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-330 and D086 Combination Therapy in Hypertensive Patients With Dyslipidemia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 154 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

To Evaluate the Efficacy and Safety of CKD-333

Detailed description

A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-330 and D086 Combination Therapy in Hypertensive Patients with Dyslipidemia

Conditions

• Hypertensive Patients With Dyslipidemia

Interventions

Type	Name	Description
DRUG	CKD-330	CKD-330 Tab.
DRUG	Placebo of CKD-330	Placebo of CKD-330 Tab.
DRUG	D086	D086 Tab.
DRUG	Placebo of D086	Placebo of D086 Tab.
DRUG	D723	D723 Tab.
DRUG	Placebo of D723	Placebo of D723 Tab.

Timeline

• Start date: 2018-04-04
• Primary completion: 2019-07-17
• Completion: 2019-07-17
• First posted: 2018-07-12
• Last updated: 2019-07-24

Locations

16 sites across 1 country: South Korea